1235 related articles for article (PubMed ID: 16978898)
1. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
3. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
Krishnan P; Stalin M; Balasubramanian S
Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
[TBL] [Abstract][Full Text] [Related]
4. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal.
Tamang MD; Oh JY; Seol SY; Kang HY; Lee JC; Lee YC; Cho DT; Kim J
Int J Antimicrob Agents; 2007 Oct; 30(4):330-5. PubMed ID: 17629465
[TBL] [Abstract][Full Text] [Related]
5. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
8. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
Verma S; Thakur S; Kanga A; Singh G; Gupta P
Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
[TBL] [Abstract][Full Text] [Related]
9. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal.
Maskey AP; Day JN; Phung QT; Thwaites GE; Campbell JI; Zimmerman M; Farrar JJ; Basnyat B
Clin Infect Dis; 2006 May; 42(9):1247-53. PubMed ID: 16586383
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: emerging and reemerging problem.
Mandal S; Mandal MD; Pal NK
J Postgrad Med; 2006; 52(3):163-6. PubMed ID: 16855314
[TBL] [Abstract][Full Text] [Related]
11. Studies on extended spectrum beta lactamase (ESBL) producing salmonella isolates from clinical samples of Nepal.
Gautam K; Pokhrel BM; Bhatta DR; Shrestha CD
Nepal Med Coll J; 2012 Sep; 14(3):204-6. PubMed ID: 24047016
[TBL] [Abstract][Full Text] [Related]
12. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
13. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital.
Amatya NM; Shrestha B; Lekhak B
JNMA J Nepal Med Assoc; 2007; 46(167):112-8. PubMed ID: 18274566
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital.
Raza S; Tamrakar R; Bhatt CP; Joshi SK
J Nepal Health Res Counc; 2012 Sep; 10(22):214-7. PubMed ID: 23281454
[TBL] [Abstract][Full Text] [Related]
15. [Multidrug resistance to antibacterial drugs of Salmonella enterica subsp. enterica strains isolated in Poland in the 1998-1999 period].
Szych J; Cieślik A; Paciorek J; Kałuzewski S
Med Dosw Mikrobiol; 2001; 53(1):17-29. PubMed ID: 11757401
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of 128 Salmonella enterica serovar typhi and paratyphi A isolates from northern India.
Safdar A; Kaur H; Elting L; Rolston KV
Chemotherapy; 2004 Jun; 50(2):88-91. PubMed ID: 15211083
[TBL] [Abstract][Full Text] [Related]
17. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
[TBL] [Abstract][Full Text] [Related]
18. Emergence of extended-spectrum beta-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran.
Hamidian M; Tajbakhsh M; Walther-Rasmussen J; Zali MR
Jpn J Infect Dis; 2009 Sep; 62(5):368-71. PubMed ID: 19762986
[TBL] [Abstract][Full Text] [Related]
19. A case of extended spectrum beta-lactamase producing Salmonella enterica serotype paratyphi A from India.
Roy P; Rawat D; Malik S
Indian J Pathol Microbiol; 2015; 58(1):113-4. PubMed ID: 25673610
[TBL] [Abstract][Full Text] [Related]
20. Extended spectrum â-lactamase producing multidrug resistant clinical bacterial isolates at National Public Health Laboratory, Nepal.
Poudyal S; Bhatta DR; Shakya G; Upadhyaya B; Dumre SP; Buda G; Kandel BP
Nepal Med Coll J; 2011 Mar; 13(1):34-8. PubMed ID: 21991699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
